Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 8

Results For "Q4"

348 News Found

Aarti Drugs Ltd Q4 FY2025 consolidated PAT climbs to Rs. 62.86 Cr
News | May 12, 2025

Aarti Drugs Ltd Q4 FY2025 consolidated PAT climbs to Rs. 62.86 Cr

The company has posted net profit of Rs.168.16 crores for the Financial Year ended March 31, 2025


Alembic Pharmaceuticals posts Q4 FY25 consolidated PAT at Rs. 156.63 Cr
News | May 06, 2025

Alembic Pharmaceuticals posts Q4 FY25 consolidated PAT at Rs. 156.63 Cr

The company has posted net profit of Rs. 582.01 crores for the Financial Year ended March 31, 2025


OneSource Specialty Pharma reports consolidated Q4 FY25 PAT at Rs. 98.50 Cr
News | May 06, 2025

OneSource Specialty Pharma reports consolidated Q4 FY25 PAT at Rs. 98.50 Cr

The company has posted net loss of Rs. 17.97 crores for the Financial Year ended March 31, 2025


Ami Organics Q4 FY25 PAT up at Rs. 62.48 Cr
News | May 05, 2025

Ami Organics Q4 FY25 PAT up at Rs. 62.48 Cr

The company has posted net profit of Rs. 158.71 crores for the Financial Year ended March 31, 2025


Tatva Chintan Pharma Chem reports consolidated Q4 FY25 PAT at Rs. 1.03 Cr
News | May 05, 2025

Tatva Chintan Pharma Chem reports consolidated Q4 FY25 PAT at Rs. 1.03 Cr

The company has posted net profit of Rs.5.71 crores for the Financial Year ended March 31, 2025


RPG Life Sciences posts Q4 FY25 net profit at Rs. 117.35 Cr
News | May 03, 2025

RPG Life Sciences posts Q4 FY25 net profit at Rs. 117.35 Cr

RPG Life Sciences has reported total income of Rs. 148.15 crores during the period ended March 31, 2025


Vimta Labs posts Q4 FY25 PAT at Rs. 18.31 Cr
News | May 01, 2025

Vimta Labs posts Q4 FY25 PAT at Rs. 18.31 Cr

Vimta Labs has reported total income of Rs. 96.08 crores during the period ended March 31, 2025


Indegene posts Q4 FY25 consolidated PAT at Rs. 117.6 Cr
News | April 29, 2025

Indegene posts Q4 FY25 consolidated PAT at Rs. 117.6 Cr

The company has posted net profit of Rs. 406.7 crores for the Financial Year ended March 31, 2025


Dr. Lal Path Labs posts Q4 FY25 consolidated PAT at Rs. 154.8 Cr
News | April 28, 2025

Dr. Lal Path Labs posts Q4 FY25 consolidated PAT at Rs. 154.8 Cr

The company has reported total income of Rs. 628.4 crores during the period ended March 31, 2025


Syngene International posts Q4 FY25 consolidated profit at Rs. 183.3 Cr
News | April 24, 2025

Syngene International posts Q4 FY25 consolidated profit at Rs. 183.3 Cr

Syngene reported revenue growth of 11% year-on-year, and 8% sequentially crossing the Rs. 1,000 Cr in a quarter threshold for the first time